Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

脱胶胰岛素 甘精胰岛素 医学 门冬氨酸胰岛素 胰岛素 糖尿病 内科学 2型糖尿病 1型糖尿病 内分泌学
作者
Simon Heller,John B. Buse,Miles Fisher,Satish K. Garg,Michel Marre,Ludwig Merker,Éric Renard,David Russell‐Jones,Areti Philotheou,Ann Marie Ocampo Francisco,Huiling Pei,Bruce W. Bode
出处
期刊:The Lancet [Elsevier BV]
卷期号:379 (9825): 1489-1497 被引量:398
标识
DOI:10.1016/s0140-6736(12)60204-9
摘要

Background Intensive basal-bolus insulin therapy has been shown to improve glycaemic control and reduce the risk of long-term complications that are associated with type 1 diabetes mellitus. Insulin degludec is a new, ultra-longacting basal insulin. We therefore compared the efficacy and safety of insulin degludec and insulin glargine, both administered once daily with mealtime insulin aspart, in basal-bolus therapy for type 1 diabetes. Methods In an open-label, treat-to-target, non-inferiority trial, undertaken at 79 sites (hospitals and centres) in six countries, adults (aged ≥18 years) with type 1 diabetes (glycated haemoglobin [HbA1c] ≤10% [86 mmol/mol]), who had been treated with basal-bolus insulin for at least 1 year, were randomly assigned in a 3:1 ratio, with a computer-generated blocked allocation sequence, to insulin degludec or insulin glargine without stratification by use of a central interactive response system. The primary outcome was non-inferiority of degludec to glargine, assessed as a reduction in HbA1c after 52 weeks, with the intention-to-treat analysis. This trial is registered with ClinicalTrials.gov, number NCT00982228. Findings Of 629 participants, 472 were randomly assigned to insulin degludec and 157 to insulin glargine; all were analysed in their respective treatment groups. At 1 year, HbA1c had fallen by 0·40% points (SE 0·03) and 0·39% points (0·07), respectively, with insulin degludec and insulin glargine (estimated treatment difference −0·01% points [95% CI −0·14 to 0·11]; p<0·0001 for non-inferiority testing) and 188 (40%) and 67 (43%) participants achieved a target HbA1c of less than 7% (<53 mmol/mol). Rates of overall confirmed hypoglycaemia (plasma glucose <3·1 mmol/L or severe) were similar in the insulin degludec and insulin glargine groups (42·54 vs 40·18 episodes per patient-year of exposure; estimated rate ratio [degludec to glargine] 1·07 [0·89 to 1·28]; p=0·48). The rate of nocturnal confirmed hypoglycaemia was 25% lower with degludec than with glargine (4·41 vs 5·86 episodes per patient-year of exposure; 0·75 [0·59 to 0·96]; p=0·021). Overall serious adverse event rates (14 vs 16 events per 100 patient-years of exposure) were similar for the insulin degludec and insulin glargine groups. Interpretation Insulin degludec might be a useful basal insulin for patients with type 1 diabetes because it provides effective glycaemic control while lowering the risk of nocturnal hypoglycaemia, which is a major limitation of insulin therapy. Funding Novo Nordisk.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
chen完成签到,获得积分10
2秒前
Hello应助ylw采纳,获得10
2秒前
3秒前
ChemistryZyh发布了新的文献求助10
3秒前
wensir发布了新的文献求助10
3秒前
端庄千琴完成签到,获得积分10
3秒前
heavennew完成签到,获得积分10
4秒前
5秒前
眼睛大樱桃完成签到,获得积分10
5秒前
Yuantian发布了新的文献求助10
6秒前
学吗你完成签到 ,获得积分10
6秒前
御青白少发布了新的文献求助10
7秒前
无尽夏完成签到,获得积分10
7秒前
Rylee发布了新的文献求助10
9秒前
9秒前
无私的念文完成签到 ,获得积分10
10秒前
充电宝应助Yuantian采纳,获得10
11秒前
水水完成签到,获得积分10
12秒前
sskr发布了新的文献求助10
12秒前
15327432191完成签到 ,获得积分10
13秒前
酷波er应助果汁采纳,获得10
13秒前
善学以致用应助程公子采纳,获得10
13秒前
海阔天空发布了新的文献求助10
13秒前
ChemistryZyh完成签到,获得积分10
14秒前
wensir完成签到,获得积分10
16秒前
斯文败类应助Rylee采纳,获得10
17秒前
养不熟的野猫完成签到,获得积分10
17秒前
sskr完成签到,获得积分10
17秒前
高文强完成签到,获得积分10
18秒前
19秒前
我是老大应助liu采纳,获得10
19秒前
领导范儿应助小熊软糖采纳,获得10
19秒前
华仔应助kevin采纳,获得10
20秒前
21秒前
22秒前
晴朗葡萄发布了新的文献求助30
22秒前
bkagyin应助冷艳的冬萱采纳,获得10
22秒前
23秒前
文献啊文献完成签到,获得积分10
24秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038569
求助须知:如何正确求助?哪些是违规求助? 3576279
关于积分的说明 11374944
捐赠科研通 3305979
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815048